Akari Therapeutics, Plc (AKTX)
NASDAQ: AKTX · Real-Time Price · USD
10.73
+1.21 (12.71%)
At close: Jun 26, 2026, 4:00 PM EDT
10.90
+0.17 (1.58%)
After-hours: Jun 26, 2026, 7:53 PM EDT
Akari Therapeutics, Market Cap
Akari Therapeutics, has a market cap or net worth of $12.28 million as of June 26, 2026. Its market cap has decreased by -69.46% in one year.
Market Cap
12.28M
Enterprise Value
10.25M
1-Year Change
-69.46%
Ranking
Category
Stock Price
$10.73
Market Cap Chart
Since September 28, 2015, Akari Therapeutics,'s market cap has decreased from $291.48M to $12.28M, a decrease of -95.79%. That is a compound annual growth rate of -25.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 12.28M | -7.18% |
| Dec 31, 2025 | 13.23M | -59.03% |
| Dec 31, 2024 | 32.30M | 83.11% |
| Dec 29, 2023 | 17.64M | -49.58% |
| Dec 30, 2022 | 34.98M | -51.00% |
| Dec 31, 2021 | 71.40M | 0.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SeaStar Medical Holding | 11.98M |
| CytoMed Therapeutics | 11.71M |
| Kiora Pharmaceuticals | 11.30M |
| OSR Health | 11.25M |
| Chemomab Therapeutics | 11.23M |
| Phio Pharmaceuticals | 11.15M |
| Intensity Therapeutics | 11.03M |
| Theriva Biologics | 10.97M |